End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,942 ARS | +4.20% |
|
+10.93% | +49.37% |
06-21 | US FDA approves Roche's drug for a chronic blood disorder | RE |
06-14 | Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto | DJ |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AMGEN INC. | Other Pharmaceuticals | +4.20% | +10.93% | +49.37% | +253.99% | +23,103.62% | 171B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- AMGN Stock
- AMGN Stock
- Charts Amgen Inc.
- Comparison Chart